CVS HEALTH Corp (CVS) stock
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3012% above fair value
$85.81−2.78 (-3.14%)
Close on Nov 17, 2026Market cap $109.75BP/E 22.8Yield 3.10%
Cvs Health r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Cvs Health
Cvs Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?